- Home
- COYA vs IAF Comparison
COYA vs IAF Comparison
Compare COYA & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COYA | IAF |
|---|---|---|
| Founded | 2020 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.7M | 120.3M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | COYA | IAF |
|---|---|---|
| Price | $4.77 | $12.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.21 | N/A |
| AVG Volume (30 Days) | ★ 130.8K | 17.2K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.44% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,945,753.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $387.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.57 | N/A |
| 52 Week Low | $3.71 | $4.36 |
| 52 Week High | $7.75 | $14.54 |
Technical Indicators
Market Signals| Indicator | COYA | IAF |
|---|---|---|
| Relative Strength Index (RSI) | 54.67 | 31.67 |
| Support Level | $4.42 | $12.33 |
| Resistance Level | $5.17 | $13.21 |
| Average True Range (ATR) | 0.26 | 0.15 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 65.69 | 0.00 |
Price Performance
Historical ComparisonAbout COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.